163 related articles for article (PubMed ID: 36970920)
1. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
[TBL] [Abstract][Full Text] [Related]
2. [miR-30b-3p Inhibits the Proliferation and Invasion of Lung Adenocarcinoma
by Targeting COX6B1].
Chen L; Chen X; Liu L; Zhao Y; Zuo W; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):567-574. PubMed ID: 36002193
[TBL] [Abstract][Full Text] [Related]
3. Novel Biomarker
Yang T; Si Q; Liu M; DU R; Ji L; Zhang X; Su J; Sun H; Wang L; Zhao C; Liu J; Ouyang S; Dai L
Anticancer Res; 2023 Nov; 43(11):4923-4935. PubMed ID: 37909971
[TBL] [Abstract][Full Text] [Related]
4. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
7. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
8. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
9. ANGPTL4, a direct target of hsa-miR-133a-3p, accelerates lung adenocarcinoma lipid metabolism, proliferation and invasion.
Hu Q; Chen S; Li Y; Hu T; Hu J; Wang C; Yang F; Yang X; Zhou F; Liu Z; Xu W; Zhang J
Aging (Albany NY); 2023 Dec; 16(9):8348-8360. PubMed ID: 38159259
[TBL] [Abstract][Full Text] [Related]
10. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
[TBL] [Abstract][Full Text] [Related]
11. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
Xu J
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.
Liang L; Xu WY; Shen A; Cen HY; Chen ZJ; Tan L; Zhang LM; Zhang Y; Fu JJ; Qin AP; Lei XP; Li SP; Qin YY; Huang JH; Yu XY
Acta Pharmacol Sin; 2022 Nov; 43(11):2946-2955. PubMed ID: 35388129
[TBL] [Abstract][Full Text] [Related]
13. The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy.
Liang L; Cen H; Huang J; Qin A; Xu W; Wang S; Chen Z; Tan L; Zhang Q; Yu X; Yang X; Zhang L
Mol Cancer; 2022 Sep; 21(1):186. PubMed ID: 36171576
[TBL] [Abstract][Full Text] [Related]
14. PP7080 expedites the proliferation and migration of lung adenocarcinoma cells via sponging miR-670-3p and regulating UHRF1BP1.
Dan W; Shi L; Wang L; Wu D; Huang X; Zhong Y
J Gene Med; 2021 Aug; 23(8):e3341. PubMed ID: 33844396
[TBL] [Abstract][Full Text] [Related]
15. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
16.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
18. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
19. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-19b-3p mediated G protein γ subunit 7 (GNG7) loss contributes lung adenocarcinoma progression through activating Hedgehog signaling.
Zhao X; Zhang XC; Zang K; Yu ZH
Bioengineered; 2021 Dec; 12(1):7849-7858. PubMed ID: 34635014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
